Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itraconazole sequential therapy for IPFI
NCT01823289Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jun 2007
- Primary completion
- Dec 2008
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of itraconazole in invasive pulmonary fungal infection, sponsored by Janssen Pharmaceutical. Started Jun 2007; status: completed.
02
Drugs
itraconazole
03
Conditions
invasive pulmonary fungal infection
Beyond the preview
Go deeper on NCT01823289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01823289.